364 results on '"Vanham, G."'
Search Results
2. Eosinophilia in Patients Infected with Human Immunodeficiency Virus [with Reply]
3. Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
4. Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
5. P18-08. Characterization of CD34+ derived dendritic cells generated in vitro and transfected with HIV gene as potential therapeutic vaccine in macaque
6. P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein
7. P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
8. P04-52 LB. The importance of well-defined HIV-1 neutralization assays
9. P04-34. Identification of 4E10-like antibodies in plasma of an HIV-1 CRF02_AG infected patient with broad neutralizing activity using peptide phage libraries
10. P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
11. GP130 and c-kit signalling, initiated by the sIL-6R/IL-6 complex, is insufficient to expand the primitive adult bone marrow CD34+CD38- pre-CFU cell
12. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells
13. Increased frequency of cytotoxic CXCR5+effector memory CD8+T cells during natural control of HIV-1 infection
14. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy (vol 20, 361, 2019)
15. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru
16. Ex vivo induction of viral antigen-specific CD8+ T cell responses using mRNA-electroporated CD40-activated B cells
17. Involvement of interleukin 18 in Crohnʼs disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models
18. DAPY non-nucleoside inhibitors of HIV-1 reverse transcriptase possess high activity in microbicide assays and have potential for prevention of sexual transmission of HIV
19. T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)
20. HIV-1 viral load and scrub typhus
21. Hyperreactive malaria in expatriates returning from sub-Saharan Africa
22. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection
23. Superantigen activation of CD4+ and CD8+ T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)
24. Macrophage-tropism of HIV-1 isolates of difference genetic subtypes
25. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-α, and additional cytokines: antagonistic effects of IL-4 and IFN-γ and selective involvement of TNF-α receptor-1
26. CD8+ T cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects
27. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection
28. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects
29. Easy and accurate reconstruction of whole HIV genomes from short-read sequence data
30. Phenotypic and Functional Parameters of Cellular Immunity in a Chimpanzee with a Naturally Acquired Simian Immunodeficiency Virus Infection
31. Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides ▿ †
32. O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype?
33. Actieve immunotherapie voor HIV-1-infectie
34. CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates
35. HIV microbicides: where are we now?
36. Ex vivo models of HIV sexual transmission and microbicide development
37. Elicitation of Neutralising Antibodies Using Patient-Derived gp140 Immunogens from a Long-Term Non-Progressor
38. An Interferon-gamma ELISPOT assay with two CTL epitopes derived from HTLV-1 Tax region 161-233 discriminates HAM/TSP patients from asymptomatic HTLV-1 carriers in a Peruvian population
39. HIV sexual transmission and microbicides
40. P06.05 Dynamics of vaginal immune correlates and microbiota in women from sub-saharan africa
41. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein
42. CADA, potential anti-HIV microbicide that specifically targets the cellular CD4 receptor
43. Evaluation de molécules à visée microbicide
44. Evaluation de la prophylaxie post-exposition
45. In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection
46. Relationships between Chemical Structure and Long-Term Exposure Microbicidal Activity within a series of HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors of the DATA and DAPY classes of compounds
47. HIV-1 viral load and scrub typhus [letter]
48. Infections, immunity and nutrition
49. Eosinophilia in patients infected with human immunodeficiency virus [letter]
50. B4 Immunotherapy of HIV-1-Infected Patients With Dendritic Cells Transfected With gag and tat-rev-nef mRNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.